Conavi Medical Corp.
CNVI.V
TSX
| 09/30/2024 | |||||
|---|---|---|---|---|---|
| Revenue | 20.33% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 20.33% | ||||
| Cost of Revenue | -2.71% | ||||
| Gross Profit | 162.26% | ||||
| SG&A Expenses | -20.44% | ||||
| Depreciation & Amortization | 8.51% | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -25.62% | ||||
| Operating Income | 27.69% | ||||
| Income Before Tax | -23.88% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -23.88% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -23.88% | ||||
| EBIT | 27.69% | ||||
| EBITDA | 28.10% | ||||
| EPS Basic | -23.75% | ||||
| Normalized Basic EPS | 6.91% | ||||
| EPS Diluted | -23.75% | ||||
| Normalized Diluted EPS | 6.91% | ||||
| Average Basic Shares Outstanding | 0.11% | ||||
| Average Diluted Shares Outstanding | 0.11% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||
